Highly Effective Combination of LSD1 (KDM1A) Antagonist and Pan-Histone Deacetylase Inhibitor Against Human AML Cells

Leukemia - United Kingdom
doi 10.1038/leu.2014.119
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor Against Human Acute Myelogenous Leukemia Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy Against Triple-Negative Human Breast Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2012English

LSD1 (KDM1A)-independent Effects of the LSD1 Inhibitor SP2509 in Cancer Cells

British Journal of Haematology
Hematology
2017English

Targeting Histone Demethylase LSD1/KDM1a in Neurodegenerative Diseases

Journal of Experimental Neuroscience
Neuroscience
2018English

Superior Activity of the Combination of Histone Deacetylase Inhibitor LAQ824 and the FLT-3 Kinase Inhibitor PKC412 Against Human Acute Myelogenous Leukemia Cells With Mutant FLT-3

Clinical Cancer Research
Cancer ResearchOncology
2004English

Cytoplasmic Translocation of Nuclear LSD1 (KDM1A) in Human Hepatoma Cells Is Induced by Its Inhibitors

Hepatic Oncology
HepatologyOncology
2019English

Histone Deacetylase Inhibitor SAHA Suppresses Human Adenovirus Gene Expression and Replication

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2019English

P66 Histone Deacetylase Inhibitor CBHA Attenuates the Expression of Plasminogen Activator Inhibitor-1 in Human Pleural Mesothelial Cells

Thorax
PulmonaryRespiratory Medicine
2010English

Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy